An elevated white blood cell count is something we see often in lab results. Coding it right isn’t always as simple as picking the first leukocytosis code that shows up in the electronic health record.
There are reasons why someone might have high white blood cells. Infections are an one. Inflammation can cause it too. Some medicines raise the count. Even stress from the body’s response to illness or injury can do it. Blood disorders, like leukemia or other hematologic issues can lead to levels as well.
For some patients the high white blood cell count is the reason they’re being tested. It’s the clue they’re looking for. For others it’s one detail among many—part of a bigger story the doctor is trying to understand.
For providers, that difference matters.
The ICD-10 code often used for leukocytosis is D72.829 which means a white blood cell count, unspecified. You should not use this code automatically just because a CBC shows a WBC count. Instead you should look for an ICD-10-CM code if the patient’s chart shows a problem such, as lymphocytosis, monocytosis, basophilia, bandemia, a leukemoid reaction or another clearly defined abnormality.
This guide explains the leukocytosis ICD-10 codes. It also covers what documentation is needed which laboratory services relate to the codes coding mistakes to avoid and tips, for sending cleaner claims.
The primary ICD-10-CM code used for unspecified leukocytosis is:
D72.829 — Elevated white blood cell count, unspecified
The code includes:
D72.829 is part of category D72. Disorders of white blood cells. Specifically it is, in the D72.82 group that covers high white blood cell counts.
When the doctor writes “leukocytosis” and does not say which type of blood cell is high D72.829 is usually the right code.
Icd-10-CM has more detailed options. These specific codes should be looked at before using a code that is not clear.
| ICD-10-CM Code | Description | When It May Apply |
|---|---|---|
| D72.829 | Elevated white blood cell count, unspecified | Unspecified leukocytosis |
| D72.828 | Other elevated white blood cell count | Other specified elevated WBC abnormalities |
| D72.820 | Lymphocytosis (symptomatic) | Elevated lymphocyte count |
| D72.821 | Monocytosis (symptomatic) | Elevated monocyte count |
| D72.822 | Plasmacytosis | Increased plasma cells |
| D72.823 | Leukemoid reaction | Markedly elevated WBC resembling leukemia |
| D72.824 | Basophilia | Elevated basophil count |
| D72.825 | Bandemia | Increased band neutrophils |
| D72.9 | Disorder of white blood cells, unspecified | Unspecified WBC disorder rather than specifically elevated WBC |
The documentation in the patient’s medical record should determine which code is selected.
The D72.82 category specifically excludes eosinophilia, which is coded separately under D72.1-. Leukemia is also coded separately within the C91-C95 ranges rather than as ordinary leukocytosis.
D72.829 is the diagnosis that most people mention when they look for the ICD‑10 code, for leukocytosis.
D72.829 is appropriate when the clinician documents a white blood cell count or leukocytosis but does not identify a more specific white blood cell abnormality.
For example:
CBC demonstrates persistent leukocytosis. Repeat CBC ordered in four weeks.
If no specific cell lineage or underlying diagnosis has been established, D72.829 may appropriately reflect the documented condition.
Another example could be:
WBC 14.8 K/µL. Patient is afebrile. Leukocytosis of unclear etiology. Will repeat CBC and evaluate further if persistent.
Here, the medical record clearly establishes leukocytosis as a condition being assessed rather than merely presenting a laboratory number.
That distinction is important for diagnosis coding.
A laboratory result that shows a high white blood cell count does not automatically mean that D72.829 should be reported.
ICD-10-CM coding should usually be based on the provider’s documented diagnosis or clinical assessment. It should not rely solely on an abnormal test result.
Suppose a CBC shows:
WBC: 15.2 × 10³/µL
but the physician documents:
Acute bacterial pneumonia with elevated WBC.
In this case the underlying infection might be the diagnosis that is driving the encounter.
If the physician specifically evaluates and documents leukocytosis as a condition leukocytosis may also be reportable depending on the encounter on payer requirements and, on coding guidelines.
Documentation should make the clinical significance clear.
When the elevated white blood cell count is specifically due to increased lymphocytes, the appropriate diagnosis may be:
D72.820 — Lymphocytosis (symptomatic)
Lymphocytosis can happen when someone has an infection or when they have long-term inflammation or blood-related diseases or reactions to medicines or other medical situations.
For example:
Lymphocytosis that stays around after blood tests. A sample of the blood and more tests about the blood were asked for.
In this situation the code D72.820 might be a way to show the patients problem, than the general code D72.829.
Specific codes make the diagnosis match better what the doctor is really looking into.
Another specific elevated WBC diagnosis is:
D72.821 — Monocytosis (symptomatic)
Monocytosis means there are monocytes in the blood than normal.
This can happen with long-term infections conditions that cause inflammation after a short-term infection has gone away some blood-related diseases and other health issues.
If the medical records clearly say monocytosis and not just a general increase, in blood cells then D72.821 should be used.
D72.822. Plasmacytosis can be used when there is evidence of an unusual rise, in plasma cells.
Plasmacytosis should not always be thought of as myeloma or some other kind of cancer that affects plasma cells. The diagnosis that is given must match what the doctor has actually found. It’s important to be careful, with labels and make sure they fit the situation not just assumptions.
When additional testing is being performed to determine the underlying cause, documentation should describe the known abnormality and the medical necessity for further evaluation.
The ICD-10-CM code for a leukemoid reaction is:
D72.823 — Leukemoid reaction
A leukemoid reaction is a rise, in white blood cells that can look like leukemia but actually comes from a different cause.
Leukemoid reaction can be triggered by infection big inflammation, tissue injury, some medicines, cancers or other physical stresses.
The diagnosis must be supported by the provider’s documentation. A very high WBC count alone should not automatically be coded as a leukemoid reaction.
D72.824 — Basophilia describes an abnormal increase in basophils.
Basophilia can sometimes be linked to inflammatory conditions, endocrine disorders, chronic inflammation or myeloproliferative diseases. I have seen that basophilia may also show up in health issues.
Because ICD‑10‑CM offers a code for basophilia an unspecified leukocytosis code should normally not replace it when the provider has clearly documented basophilia. I believe that ICD‑10‑CM expects a code, for basophilia when it is mentioned.
The ICD-10-CM code for bandemia is:
D72.825 — Bandemia
Bandemia is when there are immature neutrophils often called bands in the blood than usual.
This can happen during an infection when there is inflammation or when the body is, under stress.
The ICD-10-CM table says clearly that if there is an infection the infection should be coded instead of bandemia being the main diagnosis.
For example if a patient has confirmed sepsis and bandemia is just part of the lab results the code should focus on the infection that is already known.
D72.828 — Other elevated white blood cell count is available when the provider documents another specified type of elevated white blood cell count that does not fit one of the more specifically defined codes.
This differs from D72.829.
A useful way to remember the distinction is:
D72.828 = the abnormality is specified but does not have its own dedicated code.
D72.829 = the type of elevated WBC count is not specified.
Choosing between “other” and “unspecified” should always be based on the actual medical documentation.
Another code that can cause confusion is:
D72.9 — Disorder of white blood cells, unspecified
D72.9 describes a disorder of white blood cells and includes an abnormal leukocyte differential when no more specific diagnosis is available.
This is different, from D72.829.
If the provider writes that a white blood cell count is high or that there is leukocytosis then D72.829 is a description.
D72.9 may be used when the records show a white blood cell disorder but do not clearly say that the condition is leukocytosis.
Using the specific diagnosis that is allowed helps make a clearer claim.
One of the important things to understand in this area is the difference between leukocytosis and leukemia.
Leukocytosis just means that the count of blood cells is higher than normal.
Leukemia, on the hand is a serious illness that affects the body’s ability to make blood cells properly. It is a type of cancer.
It is possible for someone to have white blood cell counts—meaning leukocytosis—without actually having leukemia.
Because of this difference the ICD-10-CM category D72 should not be used in place of a confirmed diagnosis of leukemia.
Leukemias are generally reported within:
C91-C95 — Leukemia
The D72.8 category specifically excludes leukemia from this group.
Providers should therefore avoid coding suspected malignancies as confirmed conditions unless permitted by the applicable setting-specific coding rules.
Eosinophilia involves an increased number of a type of white blood cell. This condition has its ICD-10-CM code.
Because of this eosinophilia should not usually be coded as D72.829 especially when the provider has clearly documented the condition.
The code D72.82, which covers white blood cell counts includes an exclusion, for eosinophilia. That means eosinophilia is coded separately under D72.1-.
This highlights the importance of review. Coders and providers should not assume every elevated white blood cell count is generic leukocytosis. Instead they should look at the diagnosis and use the correct code based on the specific condition.
Leukocytosis is a finding rather than a single disease.
Common clinical causes can include:
Bacterial infections commonly cause an increased white blood cell count as the body’s immune system responds to the infection.
Depending on the clinical circumstances, the underlying infection may be the more important diagnosis to code.
Inflammatory disorders can stimulate the production and release of white blood cells.
Examples may include autoimmune diseases, inflammatory bowel disorders, tissue injury, or other inflammatory conditions.
Trauma, surgery, intense exercise, seizures, significant emotional stress, and other physiologic stressors can temporarily raise white blood cell levels.
Certain medications, including corticosteroids, can contribute to elevated white blood cell counts.
Chronic tobacco exposure can sometimes be associated with elevated WBC levels.
Persistent or unexplained leukocytosis may require evaluation for myeloproliferative disorders, leukemia, or other hematologic conditions.
White blood cell counts can rise during pregnancy and labor, so the result must be interpreted within the appropriate clinical context.
The cause of the abnormality should be documented whenever it is known.
Leukocytosis itself may not produce noticeable symptoms.
Patients may instead experience symptoms related to the underlying condition, including:
Persistent or markedly elevated WBC values may require additional evaluation depending on the patient’s clinical presentation.
The diagnostic workup depends on the patient’s history, symptoms, degree of elevation, differential count, and suspected cause.
Frequently performed tests can include:
| Test | Common CPT Code | Purpose |
|---|---|---|
| CBC with automated differential | 85025 | Evaluates WBC count and differential |
| CBC without differential | 85027 | Measures blood cell counts |
| Automated CBC | 85027/85025, depending on service | General blood count evaluation |
| Blood smear interpretation | 85060 | Microscopic evaluation of peripheral blood |
| Flow cytometry | Code varies by service | Evaluates abnormal cell populations |
| Bone marrow procedures | Code varies | Investigates suspected hematologic disease |
The procedure code should always match the actual service performed and documented.
The diagnosis code attached to the service should also support why the test was medically necessary.
CMS Medicare coverage articles, for example, include several D72 diagnoses among diagnosis codes that may support certain hematologic laboratory evaluations such as flow cytometry, although coverage ultimately depends on the specific Medicare Administrative Contractor, clinical circumstances, and applicable policy.
Good documentation makes leukocytosis coding significantly easier.
A complete note may include:
The laboratory abnormality:
Document the elevated WBC count and clinically relevant differential findings.
Clinical interpretation:
State whether the patient has leukocytosis, lymphocytosis, monocytosis, bandemia, or another identified abnormality.
Suspected or confirmed cause:
Document an infection, inflammatory condition, medication effect, hematologic disorder, or other cause when known.
Clinical significance:
Explain why the abnormality requires monitoring, further testing, treatment, or referral.
Plan:
Document repeat CBC testing, peripheral smear, hematology consultation, additional laboratory work, imaging, or other follow-up when relevant.
For example:
WBC remains elevated at 16.1 K/µL compared with 14.9 K/µL two weeks ago. Patient currently has no signs of acute infection. Persistent leukocytosis of unclear etiology. Repeat CBC with differential and peripheral smear ordered. Hematology referral will be considered if elevation persists.
This documentation provides considerably more coding and medical-necessity support than simply writing:
WBC high.
A patient visits the primary care office after routine laboratory testing shows a WBC count of 13.8 K/µL.
The provider documents:
Mild persistent leukocytosis. No clear infectious symptoms. Repeat CBC with differential ordered.
Appropriate diagnosis:
D72.829 — Elevated white blood cell count, unspecified
The clinician has established leukocytosis but has not identified a specific subtype.
A patient’s CBC demonstrates elevated lymphocytes on multiple tests.
The provider documents:
Persistent lymphocytosis. Peripheral smear ordered to evaluate further.
Potential diagnosis:
D72.820 — Lymphocytosis (symptomatic)
Using D72.829 would be less specific because the type of elevated WBC has already been documented.
A patient presents with fever, productive cough, and an elevated WBC count. Imaging and examination support bacterial pneumonia.
The physician diagnoses:
Community-acquired bacterial pneumonia with reactive leukocytosis.
The pneumonia diagnosis should generally represent the underlying condition driving the treatment.
Whether leukocytosis is additionally reported depends on its clinical significance, documentation, applicable coding guidelines, and payer requirements.
An elevated WBC number should not automatically become a leukocytosis diagnosis.
The provider should document the condition and its clinical significance.
If the record says lymphocytosis, bandemia, basophilia, or leukemoid reaction, use the code that best matches that diagnosis.
Leukocytosis does not mean the patient has leukemia.
Do not assign a malignant diagnosis simply because the WBC count is extremely elevated.
When leukocytosis results from a confirmed infection or another established disease, the underlying condition may need to take coding priority.
D72.9 describes an unspecified white blood cell disorder.
If the record specifically states elevated WBC or leukocytosis, D72.829 is usually more precise.
Claims may be more difficult to defend when documentation contains only a laboratory result without explaining why additional testing, treatment, or follow-up was necessary.
It can, depending on the test, clinical circumstances, and payer policy.
For example, persistent leukocytosis may justify repeat blood counts, peripheral smear evaluation, or more advanced hematologic testing when clinically appropriate.
However, having a valid ICD-10-CM code does not automatically guarantee coverage.
Payers may evaluate:
Practices should review payer-specific policies whenever a service has medical-necessity restrictions.
Clean coding begins before the claim reaches the payer.
Providers should document the actual diagnosis rather than relying solely on laboratory terminology. When the specific type of WBC abnormality is known, that specificity should appear in the assessment.
Medical necessity should also connect clearly to the service being ordered.
For example, a repeat CBC because of persistent leukocytosis is easier to understand from a payer’s perspective when the note clearly states that the abnormal count is being monitored.
When more complex hematologic testing is required, documentation should explain what abnormality prompted the test and what condition is being investigated.
Organizations such as Medhasty Billing Services can help practices identify coding and claim-submission issues that contribute to avoidable denials, particularly when diagnosis specificity, medical necessity, or payer requirements affect reimbursement.
Before submitting a leukocytosis diagnosis, ask three questions.
Is an elevated WBC condition actually documented?
If yes, continue.
Has the provider identified the type of white blood cell elevation?
If no, D72.829 may be appropriate.
If yes, look for a more specific code such as:
Has the underlying cause already been diagnosed?
If infection, leukemia, eosinophilia, or another condition has been established, review the applicable coding rules before reporting nonspecific leukocytosis.
The correct ICD-10 code for leukocytosis is usually D72.829 when the elevated white blood cell count is documented but the specific type has not been identified.
The key word, however, is unspecified.
When the medical record establishes lymphocytosis, monocytosis, plasmacytosis, a leukemoid reaction, basophilia, bandemia, or another specific abnormality, a more detailed ICD-10-CM code may provide a better representation of the patient’s condition.
Providers should also avoid treating an abnormal CBC result as a diagnosis without clinical documentation. A clear assessment connecting the laboratory finding to the patient’s evaluation, treatment, or follow-up supports both clinical continuity and cleaner claim submission.
For practices dealing with recurring diagnosis-code mismatches, laboratory-related denials, medical-necessity issues, or other revenue cycle challenges, Medhasty Billing Services can support more accurate coding workflows and help ensure claims better reflect the care documented in the patient’s record.
The ICD-10-CM code most commonly used for unspecified leukocytosis is D72.829 — Elevated white blood cell count, unspecified.
Yes. D72.829 includes unspecified leukocytosis and unspecified elevated leukocytes.
When the provider documents an elevated white blood cell count without identifying a more specific subtype, D72.829 is generally appropriate.
The ICD-10-CM code for symptomatic lymphocytosis is D72.820.
The ICD-10-CM code for bandemia is D72.825.
D72.828 represents another specified elevated white blood cell count, while D72.829 represents an elevated white blood cell count that has not been further specified.
Possibly, depending on the clinical circumstances and applicable coding rules. If leukocytosis is simply part of the expected presentation of a confirmed infection, separately reporting it may not always be appropriate. Providers should document whether the leukocytosis represents a distinct clinically significant condition requiring evaluation or management.
No. Leukocytosis means the white blood cell count is elevated. Leukemia is a malignant hematologic disease and is coded separately.
Let our medical billing experts optimize your revenue cycle management. We enable healthcare practices to increase cash flow and avoid denials. Permanently!
